{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:12:09Z","timestamp":1792725129051,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000521"],"award-info":[{"award-number":["82000521"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102797"],"award-info":[{"award-number":["82102797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.tranon.2023.101776","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T18:11:45Z","timestamp":1693851105000},"page":"101776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Comprehensive analysis of P2Y family genes expression, immune characteristics, and prognosis in pan-cancer"],"prefix":"10.1016","volume":"37","author":[{"given":"Chuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongbiao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4228-6508","authenticated-orcid":false,"given":"Weiguo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2023.101776_bib0001","unstructured":"World Health Organization. Cancer Today. Available at: https:\/\/gco.iarc.fr\/today\/home. (Accessed 3 August 2023)."},{"issue":"1","key":"10.1016\/j.tranon.2023.101776_bib0002","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.tranon.2023.101776_bib0003","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2023.101776_bib0004","article-title":"Distant metastasis pattern and prognostic prediction model of colorectal cancer patients based on big data mining","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2023.101776_bib0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuropharm.2015.10.030","article-title":"Pharmacology and structure of p2y receptors","volume":"104","author":"von Kugelgen","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tranon.2023.101776_bib0006","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev-immunol-051116-052406","article-title":"Purine release, metabolism, and signaling in the inflammatory response","volume":"37","author":"Linden","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.tranon.2023.101776_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114406","article-title":"P2y receptors for extracellular nucleotides: contributions to cancer progression and therapeutic implications","volume":"187","author":"Woods","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.tranon.2023.101776_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093337","article-title":"Nlrc4, asc and caspase-1 are inflammasome components that are mediated by p2y2r activation in breast cancer cells","volume":"21","author":"Jin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.tranon.2023.101776_bib0009","article-title":"P2y purinergic signaling in prostate cancer: emerging insights into pathophysiology and therapy","volume":"1877","author":"Khalafalla","year":"2022","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tranon.2023.101776_bib0010","article-title":"P2ry14 is a potential biomarker of tumor microenvironment immunomodulation and favorable prognosis in patients with head and neck cancer","volume":"12","author":"Li","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.tranon.2023.101776_bib0011","doi-asserted-by":"crossref","first-page":"e11319","DOI":"10.7717\/peerj.11319","article-title":"Identification of p2ry13 as an immune-related prognostic biomarker in lung adenocarcinoma: a public database-based retrospective study","volume":"9","author":"Lin","year":"2021","journal-title":"PeerJ"},{"issue":"20","key":"10.1016\/j.tranon.2023.101776_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26206146","article-title":"P2y12 purinergic receptor and brain tumors: implications on glioma microenvironment","volume":"26","author":"Morrone","year":"2021","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.tranon.2023.101776_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194887","article-title":"Colorectal cancer and purinergic signalling: an overview","volume":"14","author":"Roliano","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2023.101776_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101621","article-title":"Editorial: attention to finer-details: progression from bulk to single-cell studies","volume":"29","author":"Dwivedi","year":"2023","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2023.101776_bib0015","doi-asserted-by":"crossref","first-page":"18938","DOI":"10.1038\/s41598-019-55194-8","article-title":"Synthesis and preclinical validation of novel p2y1 receptor ligands as a potent anti-prostate cancer agent","volume":"9","author":"Le","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2023.101776_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104808","article-title":"P2y2 receptors mediate nucleotide-induced egfr phosphorylation and stimulate proliferation and tumorigenesis of head and neck squamous cell carcinoma cell lines","volume":"109","author":"Woods","year":"2020","journal-title":"Oral Oncol."},{"key":"10.1016\/j.tranon.2023.101776_bib0017","article-title":"Therapeutic potential for p2y2 receptor antagonism","author":"Jasmer","year":"2022","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.tranon.2023.101776_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173687","article-title":"P2y2 receptor activation promotes esophageal cancer cells proliferation via erk1\/2 pathway","volume":"891","author":"Zaparte","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"7139","key":"10.1016\/j.tranon.2023.101776_bib0019","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/nature05704","article-title":"Udp acting at p2y6 receptors is a mediator of microglial phagocytosis","volume":"446","author":"Koizumi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2023.101776_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128981","article-title":"Synthesis and pharmacological characterization of multiply substituted 2h-chromene derivatives as p2y6 receptor antagonists","volume":"75","author":"Jung","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tranon.2023.101776_bib0021","doi-asserted-by":"crossref","DOI":"10.1007\/s11302-022-09888-w","article-title":"P2y12 receptor antagonism inhibits proliferation, migration and leads to autophagy of glioblastoma cells","author":"Vargas","year":"2022","journal-title":"Purinergic Signal"},{"issue":"7908","key":"10.1016\/j.tranon.2023.101776_bib0022","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-022-04632-1","article-title":"Programme of self-reactive innate-like t cell-mediated cancer immunity","volume":"605","author":"Chou","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.tranon.2023.101776_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051098","article-title":"Control of macrophage inflammation by p2y purinergic receptors","volume":"10","author":"Klaver","year":"2021","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.tranon.2023.101776_bib0024","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.tranon.2023.101776_bib0025","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.21037\/apm-19-670","article-title":"The efficacy and safety comparison of pd-1\/pd-l1 antibody, chemotherapy and supportive treatment for pretreated advanced esophagogastric cancer: a network meta-analysis","volume":"9","author":"Liu","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.tranon.2023.101776_bib0026","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13578-020-0379-7","article-title":"Dna mismatch repair in the context of chromatin","volume":"10","author":"Huang","year":"2020","journal-title":"Cell Biosci."},{"issue":"3","key":"10.1016\/j.tranon.2023.101776_bib0027","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"Emt transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.tranon.2023.101776_bib0028","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13046-019-1196-x","article-title":"Anti-emt properties of coq0 attributed to pi3k\/akt\/nfkb\/mmp-9 signaling pathway through ros-mediated apoptosis","volume":"38","author":"Yang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2023.101776_bib0029","first-page":"138","article-title":"P2y2 receptor promotes the migration and invasion of breast cancer cells via emt-related genes snail and e-cadherin","volume":"39","author":"Qiu","year":"2018","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.tranon.2023.101776_bib0030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.molonc.2015.09.006","article-title":"Altered purinergic receptor-ca(2)(+) signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells","volume":"10","author":"Azimi","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.tranon.2023.101776_bib0031","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-030-30651-9_4","article-title":"Calcium signaling in glioma cells: the role of nucleotide receptors","volume":"1202","author":"Wypych","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tranon.2023.101776_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108649","article-title":"Extracellular atp modulates podocyte function through p2y purinergic receptors and pleiotropic effects on ampk and camp\/pka signaling pathways","volume":"695","author":"Szrejder","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.tranon.2023.101776_bib0033","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.biochi.2012.04.006","article-title":"The p2y2\/src\/p38\/cox-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells","volume":"94","author":"Limami","year":"2012","journal-title":"Biochimie"},{"issue":"5 Pt A","key":"10.1016\/j.tranon.2023.101776_bib0034","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.bbadis.2018.02.008","article-title":"The g protein-coupled p2y(6) receptor promotes colorectal cancer tumorigenesis by inhibiting apoptosis","volume":"1864","author":"Placet","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.tranon.2023.101776_bib0035","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41588-022-01088-x","article-title":"Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer","volume":"54","author":"Becker","year":"2022","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.tranon.2023.101776_bib0036","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1159\/000485495","article-title":"Emodin inhibits atp-induced proliferation and migration by suppressing p2y receptors in human lung adenocarcinoma cells","volume":"44","author":"Wang","year":"2017","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523323001626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523323001626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:28:40Z","timestamp":1761845320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523323001626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":36,"alternative-id":["S1936523323001626"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2023.101776","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of P2Y family genes expression, immune characteristics, and prognosis in pan-cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2023.101776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101776"}}